C1GALT1P3

Across TCGA pan-cancer cohorts, C1GALT1P3 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of C1GALT1P3’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where C1GALT1P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types C1GALT1P3 is over-expressed in tumor.

LUAD, BRCA, and STAD are the cancer types where C1GALT1P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in C1GALT1P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Male	All	+0.070	.002	4	view →
BRCA	All	III,IV	+0.016	.041	2	view →
STAD	All	All	+0.030	.014	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

C1GALT1P3–LUAD

Open the LUAD breakdown →